Tribe Public Event - Tuesday, September 21, 2021 - InMed Pharmaceuticals (NASDAQ: INM) "Accelerating The Commercialization of Rare Cannabinoids"
We are excited to be hosting Tribe Public's Next Webinar Presentation and Q&A Event which will be held Tuesday, September 21, 2021 (8:30 am PT/ 11:30 am ET). Our events are approximately 30 minutes in duration.
Eric A. Adams, MIBS, CEO & President of InMed Pharmaceuticals (NASDAQ: INM) & Shane Johnson, MD, Co-Founder of BayMedica will deliver a presentation titled "Accelerating The Commercialization of Rare Cannabinoids." They will be also be available for a 5-10 minute Q&A session at the end of the presentation. Send Questions For management to email: firstname.lastname@example.org.
InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol ("CBN") and is developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.inmedpharma.com.
On Monday, September 13th, InMed announced that it had entered into a definitive agreement to acquire BayMedica Inc., a company that specializes in the manufacturing/commercialization of rare cannabinoids. Upon closing, InMed will become a global leader in the manufacturing of rare cannabinoids, with expertise in three distinct and complementary cannabinoid manufacturing approaches. InMed’s proprietary cannabinoid manufacturing process, IntegraSyn™, combined with BayMedica’s synthetic biology and chemical synthesis capabilities, will provide InMed with complete manufacturing flexibility to select the most appropriate, cost-effective method based on the target cannabinoid and appropriate quality specifications for the desired market segment.
By registering for this event you are agreeing to join Tribe Public (www.tribepublic.com) & to receive future FREE invitations. Disclaimer: https://tribepublic.com/disclaimers.